Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 23(18): 8124-8129, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31599440

RESUMO

OBJECTIVE: Samter's triad is the combination of asthma, aspirin sensitization, and nasal polyposis. Few data are available on the use of omalizumab in this disease. The study aimed to describe the impact of omalizumab on clinical and functional parameters and the quality of life of a series of patients with Samter's triad. Moreover, we aimed to provide a review of the literature on this topic. PATIENTS AND METHODS: We retrospectively described four patients with Samter's triad undergoing omalizumab therapy. Clinical, functional, and immunological data of these patients were collected at baseline and follow-up. RESULTS: Reduction of asthma exacerbations and salbutamol rescue therapy were observed in all patients after anti-IgE treatment together with an improvement in the quality of life. A significant improvement in FEV1, FVC, and FEF25-75 was observed. No major side-effects were observed. A total of 14 studies regarding omalizumab in aspirin-exacerbated respiratory diseases were included in the review, comprising 78 patients. All studies reported a good efficacy in improving asthma control; restoration of aspirin tolerance was repeatedly reported. CONCLUSIONS: The results of our case series and review of the literature suggest that omalizumab effectively improves asthma control, lung function tests, and quality of life in patients with Samter's triad.


Assuntos
Antiasmáticos/uso terapêutico , Asma Induzida por Aspirina/tratamento farmacológico , Pólipos Nasais/tratamento farmacológico , Omalizumab/uso terapêutico , Adulto , Idoso , Asma/tratamento farmacológico , Asma/fisiopatologia , Asma Induzida por Aspirina/fisiopatologia , Intervalo Livre de Doença , Hipersensibilidade a Drogas/tratamento farmacológico , Hipersensibilidade a Drogas/fisiopatologia , Feminino , Volume Expiratório Forçado , Humanos , Masculino , Fluxo Máximo Médio Expiratório , Pessoa de Meia-Idade , Pólipos Nasais/fisiopatologia , Hipersensibilidade Respiratória/tratamento farmacológico , Hipersensibilidade Respiratória/fisiopatologia , Teste de Desfecho Sinonasal , Terapêutica , Capacidade Vital
2.
High Blood Press Cardiovasc Prev ; 25(2): 209-218, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29582365

RESUMO

INTRODUCTION: Recently new treatment options have substantially increased survival for patients with relapsed and/or refractory multiple myeloma (RRMM). Among these, proteasome inhibitors (PI), such as bortezomib and carfilzomib, offer high response rate and prolonged survival. These agents are generally well tolerated but demonstrated a significant cardiovascular toxicity, mostly for regimen containing carfilzomib. AIM: To assess the cardiovascular damage in patients treated with PI for RRMM. METHODS: 28 consecutive subjects treated with PI for RRMM were evaluated and compared with a population of 22 control (Con) subjects, matched for age, sex and mean 24 h blood pressure (24hMBP). All individuals underwent trans-thoracic echocardiography, ambulatory blood pressure monitoring and pulse wave velocity (PVW) study. RESULTS: PI patients did not have significant differences in blood pressure load and PWV compared to controls. Among echocardiographic parameters, the global longitudinal strain (GLS) was significantly decreased in PI subjects (p = 0.02). The GLS was significantly lower also considering only patients treated with carfilzomib. Moreover, among carfilzomib patients, we found increase values of left ventricle mass indexed by BSA (LVMi; p = 0.047). After correction for age, sex, BSA, 24hMBP and morphological and functional parameters of LV, treatment with PI and carfilzomib were significantly associated with GLS (p = 0.01; p = 0.036, respectively). CONCLUSIONS: PI treatment is associated with subclinical LV dysfunction in patients with RRMM compared to controls, as demonstrated by lower GLS values. These results are confirmed also considering patients treated with carfilzomib. Moreover, in this subgroup of patients, the LVMi is also increased, suggesting higher cardiotoxicity with this treatment.


Assuntos
Antineoplásicos/efeitos adversos , Mieloma Múltiplo/tratamento farmacológico , Oligopeptídeos/efeitos adversos , Complexo de Endopeptidases do Proteassoma/efeitos dos fármacos , Inibidores de Proteassoma/efeitos adversos , Disfunção Ventricular Esquerda/induzido quimicamente , Idoso , Doenças Assintomáticas , Bortezomib/efeitos adversos , Cardiotoxicidade , Estudos de Casos e Controles , Ecocardiografia Doppler , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mieloma Múltiplo/diagnóstico , Mieloma Múltiplo/enzimologia , Complexo de Endopeptidases do Proteassoma/metabolismo , Fatores de Risco , Resultado do Tratamento , Disfunção Ventricular Esquerda/diagnóstico por imagem , Disfunção Ventricular Esquerda/fisiopatologia , Função Ventricular Esquerda/efeitos dos fármacos
3.
Leukemia ; 31(8): 1727-1734, 2017 08.
Artigo em Inglês | MEDLINE | ID: mdl-28008174

RESUMO

In newly diagnosed myeloma patients, upfront autologous transplant (ASCT) prolongs progression-free survival 1 (PFS1) compared with chemotherapy plus lenalidomide (CC+R). Salvage ASCT at first relapse may still effectively rescue patients who did not receive upfront ASCT. To evaluate the long-term benefit of upfront ASCT vs CC+R and the impact of salvage ASCT in patients who received upfront CC+R, we conducted a pooled analysis of 2 phase III trials (RV-MM-209 and EMN-441). Primary endpoints were PFS1, progression-free survival 2 (PFS2), overall survival (OS). A total of 268 patients were randomized to 2 courses of melphalan 200 mg/m2 and ASCT (MEL200-ASCT) and 261 to CC+R. Median follow-up was 46 months. MEL200-ASCT significantly improved PFS1 (median: 42 vs 24 months, HR 0.53; P<0.001), PFS2 (4 years: 71 vs 54%, HR 0.53, P<0.001) and OS (4 years: 84 vs 70%, HR 0.51, P<0.001) compared with CC+R. The advantage was noticed in good and bad prognosis patients. Only 53% of patients relapsing from CC+R received ASCT at first relapse. Upfront ASCT significantly reduced the risk of death (HR 0.51; P=0.007) in comparison with salvage ASCT. In conclusion, these data confirm the role of upfront ASCT as the standard approach for all young myeloma patients.


Assuntos
Mieloma Múltiplo/terapia , Transplante de Células-Tronco , Talidomida/análogos & derivados , Administração Oral , Adulto , Idoso , Ensaios Clínicos Fase III como Assunto , Humanos , Lenalidomida , Pessoa de Meia-Idade , Mieloma Múltiplo/mortalidade , Terapia de Salvação , Talidomida/uso terapêutico , Transplante Autólogo
4.
Schweiz Arch Tierheilkd ; 155(4): 219-28, 2013 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-23531943

RESUMO

Aim of this study is to present a survey of the dog population and breed distribution in Switzerland from 1955 to 2008 as basis to realize a population based canine cancer register for Switzerland. The number of dogs rose from 309'000 in 1955 to approximately 500'000 in 2008 correlating with a parallel increase of human population. The ratio of dogs per 100 inhabitants remains stable. This ratio is lower in German speaking compared to French or Italian speaking Cantons. The variety and popularity of breeds changed from 1955 to 2008, "winners" are Labrador and Golden Retrievers, Yorkshire and Jack Russel Terriers. Less popular breeds over the years are German Sheherd dogs and Poodles.


Assuntos
Cães/classificação , Animais , Demografia , Crescimento Demográfico , Suíça
5.
Haematologica ; 82(5): 581-3, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9407725

RESUMO

BACKGROUND AND OBJECTIVE: It has been previously suggested that activation of coagulation and fibrinolysis may sometime occur in patients with unruptured aortic aneurysm. However, the incidence of this complication and the effect of surgical repair are unknown. The objective of our study was to gain further information on this topic. METHODS: We investigated activation of the hemostatic process in 20 consecutive patients with unruptured abdominal aortic aneurysm. We then evaluated the effect of surgical repair of the vascular abnormalities. RESULTS: Both before and in the first week after surgery, the large majority of patients showed clear signs of activation of coagulation (increased plasma levels of prothrombin fragment 1 + 2 and fibrin peptide A), and many had low levels of the natural anticoagulant antithrombin III. Platelets were activated in all cases (high levels of plasma beta-thromboglobulin), and signs of platelet consumption (thrombocytopenia and/or increased mean platelet volume) were present in most of them. INTERPRETATION AND CONCLUSIONS: Activation of the hemostatic process occurs in nearly all patients with abdominal aortic aneurysm and could play a role in the hemorrhagic and thrombotic events that can complicate the clinical development of these subjects.


Assuntos
Aneurisma da Aorta Abdominal/fisiopatologia , Aneurisma da Aorta Abdominal/cirurgia , Hemostasia , Idoso , Feminino , Humanos , Masculino , Agregação Plaquetária , Período Pós-Operatório , Estudos Prospectivos , Trombina/metabolismo
6.
Minerva Ginecol ; 47(3): 57-61, 1995 Mar.
Artigo em Italiano | MEDLINE | ID: mdl-7630510

RESUMO

39 patients affected by CIN had undergone radio surgical excision. This non-traumatic method employs 3.8 MHz radio waves are employed to cut and/or coagulate. The radio surgical excision was carried out by a loop electrode, or microneedle, according to the colposcopic, histologic and microcolpohysteroscopic characteristics of the cervical lesion. In fact 14 patients, among whom 11 affected by CIN I and 4 by CIN II with a total visibility of squamous columnar junction and not extended lesion of the cervical canal, had undergone radio surgical excision through various dimensions loop according to the size of the tissue to be excised. Whereas 10 CIN II patients who had not entirely visible squamous columnar junction or large cervical canal lesion, and 14 CIN III patients underwent to radiosurgical conization through a subtle and extensible tungsten thread according to the size of the tissue to be excised. In the 100% of the both groups the recovery was confirmed after three and six months. Inno cases cervical canal stenosis was observed and the squamous columnar junction resulted well visible. In both groups no thermal damages on the excised tissue, which could create difficulties on the histological diagnosis, were observed. Therefore, this method resulted an easy and cheap technique to be executed in surgery with excellent results under the therapeutic and economical aspect.


Assuntos
Radiocirurgia/métodos , Displasia do Colo do Útero/cirurgia , Adulto , Eletrocoagulação , Feminino , Humanos , Microcirurgia , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Radiocirurgia/instrumentação , Displasia do Colo do Útero/patologia
7.
J Cardiovasc Surg (Torino) ; 32(6): 775-7, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1752898

RESUMO

A 18 years male had congenital hypoplasia of the right external iliac artery and thrombosis of its narrowest part. Congenital megacolon, anal atresia and hyposomical nanism were also present. Surgical intervention was indicated because he was developing arterial insufficiency and muscular hypotrophy of the right leg. A bypass was performed with a reversed autogenous vein between the common iliac artery and the common femoral artery.


Assuntos
Artéria Ilíaca/anormalidades , Trombose/etiologia , Anormalidades Múltiplas/patologia , Adolescente , Prótese Vascular , Artéria Femoral/cirurgia , Humanos , Perna (Membro)/irrigação sanguínea , Masculino , Trombose/cirurgia
9.
Arch Sci Med (Torino) ; 140(1): 45-50, 1983.
Artigo em Italiano | MEDLINE | ID: mdl-6409052

RESUMO

The Mitomycin are a family of antibiotics useful in the treatment of breast, lung, stomach, colorectal and other solid tumours. One member of the family, MC (Mitomycin C) is examined and the present biochemical, physiological, microbiological, pharmacological and clinical knowledge of the drug and its use in laryngeal tumours is reviewed.


Assuntos
Neoplasias Laríngeas/tratamento farmacológico , Mitomicinas/uso terapêutico , Ensaios Clínicos como Assunto , DNA/biossíntese , Replicação do DNA/efeitos dos fármacos , Humanos , Mitomicina , Mitomicinas/efeitos adversos
10.
Tumori ; 67(2): 105-8, 1981.
Artigo em Inglês | MEDLINE | ID: mdl-7256876

RESUMO

Histones prepared from human lung and human lung carcinoma were analyzed by a 2-dimensional electrophoresis method able to separate histone subfractions. The comparative analysis of electrophoretograms showed differences in the relative amounts of H1, H2A, and H3 histone subfractions extracted from human lung and human lung carcinoma chromatin.


Assuntos
Histonas/análise , Pulmão/análise , Eletroforese em Gel de Poliacrilamida , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA